JPMorgan Chase Reduces Stake in Hologic, Inc.

Medical equipment provider Hologic sees institutional ownership shift as major investor trims position.

Mar. 19, 2026 at 9:21am

Got story updates? Submit your updates here. ›

JPMorgan Chase & Co. decreased its stake in shares of Hologic, Inc. (NASDAQ:HOLX) by 12.5% during the 3rd quarter, according to the company's recent SEC filing. The firm owned 1,108,008 shares of the medical equipment provider's stock after selling 158,615 shares during the quarter.

Why it matters

Hologic is a major player in the medical technology industry, specializing in women's health products and services. Changes in institutional ownership of the company's stock can signal shifts in investor sentiment and market expectations.

The details

According to the SEC filing, JPMorgan Chase & Co. reduced its position in Hologic, Inc. by 12.5% in the third quarter of 2026. The firm previously owned 1,108,008 shares, representing approximately 0.50% of Hologic's outstanding stock. Other major institutional investors in Hologic include The Manufacturers Life Insurance Company and Invesco Ltd.

  • JPMorgan Chase & Co. reduced its Hologic stake in the 3rd quarter of 2026.

The players

JPMorgan Chase & Co.

A multinational investment bank and financial services company headquartered in New York City.

Hologic, Inc.

A global medical technology company specializing in women's health products and services, including diagnostic equipment, imaging systems, and surgical solutions.

Got photos? Submit your photos here. ›

The takeaway

The reduced stake by JPMorgan Chase in Hologic could signal a shift in investor sentiment around the medical equipment provider, though the overall institutional ownership remains high. Analysts will likely monitor Hologic's performance and any further changes in major shareholder positions.